Westminster Health Forum

Since lockdown, we have been organising our full programme of conferences online. We will continue online until further notice, to ensure we play our part in helping our employees and delegates to remain safe during this time. We are pleased that so many key stakeholders, policymakers and other interested parties - both old friends and new delegates - are taking up the opportunity to discuss public policy issues and network at our impartial seminars. New events are coming on to our conference programme all the time. So there are plenty of opportunities for you to join us if you haven’t already, from wherever you are. For booking-related queries, or information on speaking, please email us at info@forumsupport.co.uk or contact us using one of the following numbers: +44 (0)7951044809 / +44 (0)7503591880 / +44 (0)7538736244.
For delegates already booked on, we will send you the online joining instructions (including links, event numbers and passwords) five working days before your conference. If you cannot find these in your inbox please email delegate.relations@forumsupport.co.uk

Regulation of medicines, clinical trials and medical devices in the UK

May 2019

This seminar was a timely opportunity to discuss the future for the regulation of medicines, clinical trials and medical devices in the UK.

Attendees discussed what more could be done to ensure that the regulatory process supports the development of new treatments within the UK - in light of the publication of the NHS Long Term Plan and additional investment in the Life Sciences Sector Deal 2, which set out sector and government actions to promote innovative regulation.

The seminar followed the Department of Health and Social Care’s announcement that the Accelerated Access Collaborative (AAC) will become a new organisation for innovation to speed up the uptake of pioneering treatments.

There was discussion on the role of the AAC in quickening the pace of the regulatory approval process for proven innovations - as well as what further support could be provided to innovators.

Delegates assessed the changing landscape of healthcare regulation and the future role of the UK in European regulatory procedures - including key issues for maintaining access, innovation and the supply of medicines to the UK.  

Sessions focused on priorities for the Health Research Authority as it develops a new strategy for clinical trials transparency, ahead of the expected publication later this year - such as if further funding will be needed, how improvements in transparency will be measured and how non-compliance with transparency regulations should be responded to.  

Price: £95 PLUS VAT

Shortly after every Westminster Health Forum seminar, a briefing document is produced. This is distributed to all delegates on the day as well as to our policymaker contacts in government, and to stakeholders more widely.

A seminar publication provides a timely record of proceedings, and acts as a guide to the latest thinking on current policy issues for those unable to be at the event.

This publication includes


Contributions from keynotes and panellists, including accompanying slides*
*Subject to approval

Delegate Pack

Information from the day, including delegate list, biographies and agenda


Transcript of questions and comments posed to speakers from attending delegates


Supplementary articles from speakers
and delegates